PARIS -
(BUSINESS WIRE) -- Bureau Veritas, a global leader in Testing, Inspection and Certification (TIC), is pleased to announce the appointment of Santiago Arias Duval, effective November 17th, 2025, as Executive Vice-President, Americas. This appointment is in line with Bureau Veritas’ new operating model effective since September 1st, 2025.

Bureau Veritas is evolving the structure of its executive committee to drive greater organizational alignment. This organization will empower the regions with scalable Product Lines, enabling global solutions development, and will be unlocking wider cross-selling opportunities.

The Americas region is created to leverage fast developing market opportunities across countries in North, Central and South America. This is a dynamic region for all Bureau Veritas where the group intends to expand its leadership across product lines and create new strongholds in high growth markets. The new Americas region organization will facilitat ... Read more »

ZUG, Switzerland
At ASDS 2025, Galderma unveiled pivotal new data from its range of pioneering Restylane® hyaluronic acid (HA) injectables, highlighting its versatility in improving the chin profile with Restylane Lyft™, temple volume with investigational Restylane Contour™* and skin quality in the décolletage (neckline) with investigational Restylane Skinboosters™*1-3
Nine-month results from a first-of-its-kind clinical trial were presented, reinforcing that the treatment regimen of Restylane Lyft or Restylane Contour with Sculptra® delivers sustained aesthetic facial improvements for patients experiencing facial aesthetic changes after medication-driven weight loss4
The company also presented new phase III data on its investigational product Relfydess™ (RelabotulinumtoxinA)* relating to its rapid onset as early as day one and long duration of effect on frown lines and crow’s feet5


(BUSINESS WIRE) -- Galderma (SIX: GALD), the pure-play dermatology category lea ... Read more »

ZUG, Switzerland -
(BUSINESS WIRE) -- NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION.

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche CHF 175 million Swiss franc-denominated bond. The bond has a maturity of 5 years and carries a fixed-rate annual coupon of 0.9425%.

Net proceeds from the transaction will be used to partially refinance Galderma’s existing bank term loan issued at its initial public offering (IPO) in March 2024, as well as for general corporate purposes. This marks the company’s third CHF-bond issuance since listing.

The new bond will be listed on the SIX Swiss Exchange, with the settlement date expected on December 10, 2025. BNP Paribas and UBS jointly led the transaction.

Galderma is rated BBB (stable outlook) by Fitch. The same rating is also expect ... Read more »

ITASCA, Ill. -
Jakarta office launches in response to demand for logistics expertise in Southeast Asia

(BUSINESS WIRE) -- As part of its ongoing organic expansion strategy, global supply chain solutions leader, AIT Worldwide Logistics, opened its first office in Jakarta, Indonesia. The new facility represents the eighth country in the AIT-Asia network and exemplifies the company’s adaptability and flexibility in response to customer demands in the region.

According to AIT’s Chief Strategy Officer, Greg Weigel, the team in Jakarta will collaborate with AIT’s expansive global network to quickly customize sea, air and road solutions unique to each client’s organizational needs, with a particular focus on the region’s flourishing industrial, technology and telecommunications sectors.

“Jakarta is a pivotal market for us as we continue our expansion in Asia,” Weigel said. “By establishing our presence in Indonesia, we’re not only positioning AIT to tap into a regio ... Read more »

MUNICH - Friday, 14. November 2025 AETOSWire


(BUSINESS WIRE) -- 3Q 2025

Double-digit growth in operating profit and shareholders’ core net income

Total business volume rises 5.21 percent with contributions from all segments

Operating profit increases 12.6 percent to 4.4 billion euros, with particular strong contribution from the Property-Casualty segment

Shareholders’ core net income advances by 12.7 percent and reaches 2.9 billion euros

9M 2025

Continued strong and diversified growth across our businesses and record operating profit

Total business volume rises 8.5 1 percent and reaches 141.2 billion euros with contributions from all segments

Operating profit increases 10.4 percent to 13.1 billion euros, our highest nine-month operating profit ever, reaching 82 percent of our full-year outlook midpoint

Shareholders’ core net income advances 10.5 percent to 8.4 billion euros. Adjusted for the one-off tax provi ... Read more »